These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
483 related articles for article (PubMed ID: 26862650)
1. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA. Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650 [TBL] [Abstract][Full Text] [Related]
2. Relationship of in vivo and ex vivo levels of TH1 and TH2 cytokines with viremia in HAART patients with and without opportunistic infections. Sindhu S; Toma E; Cordeiro P; Ahmad R; Morisset R; Menezes J J Med Virol; 2006 Apr; 78(4):431-9. PubMed ID: 16482539 [TBL] [Abstract][Full Text] [Related]
3. Short communication: decreasing soluble CD30 and increasing IFN-gamma plasma levels are indicators of effective highly active antiretroviral therapy. Sadeghi M; Süsal C; Daniel V; Naujokat C; Zimmermann R; Huth-Kühne A; Opelz G AIDS Res Hum Retroviruses; 2007 Jul; 23(7):886-90. PubMed ID: 17678471 [TBL] [Abstract][Full Text] [Related]
4. CD4+ cells recovery in HIV positive patients with severe immunosuppression at HAART initiation at Centre Medico-Social Cor-Unum, Kigali. Merci NM; Emerence U; Augustin N; Habtu M; Julie I; Angelique T; Jessica B; Cynthia A; Penda AT Pan Afr Med J; 2017; 26():14. PubMed ID: 28450993 [TBL] [Abstract][Full Text] [Related]
5. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients. Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174 [TBL] [Abstract][Full Text] [Related]
6. Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort. Kapogiannis BG; Henderson SL; Nigam P; Sharma S; Chennareddi L; Herndon JG; Robinson HL; Amara RR AIDS Res Hum Retroviruses; 2006 Mar; 22(3):272-82. PubMed ID: 16545014 [TBL] [Abstract][Full Text] [Related]
7. HIV DNA and immune alteration during successful HAART. Mamadou D; Yu-Huang Z; Xia C; Bo H; Hua-Ying Z; Yan H; Zi C; Qing L; Li-Wen Z; Mei H; Yun-Hai Y; Demba S; Aldebert D; Souleymane M Curr HIV Res; 2013 Jun; 11(4):255-62. PubMed ID: 23822818 [TBL] [Abstract][Full Text] [Related]
8. Synergistic immunosuppression by candida in HIV infection: a cytokine based analysis. Bajaj JS; Singh A; Aggarwal SK; Chattopadhya D; Baveja UK J Commun Dis; 2000 Mar; 32(1):1-9. PubMed ID: 11186879 [TBL] [Abstract][Full Text] [Related]
10. Magnitude of IFN-gamma production in HIV-1-infected children is associated with virus suppression. Reuben JM; Lee BN; Paul M; Kline MW; Cron SG; Abramson S; Lewis D; Kozinetz CA; Shearer WT J Allergy Clin Immunol; 2002 Aug; 110(2):255-61. PubMed ID: 12170266 [TBL] [Abstract][Full Text] [Related]
11. IL-2 and IL-10 serum levels in HIV-1-infected patients with or without active antiretroviral therapy. Orsilles MA; Pieri E; Cooke P; Caula C APMIS; 2006 Jan; 114(1):55-60. PubMed ID: 16499662 [TBL] [Abstract][Full Text] [Related]
12. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. Klein SA; Dobmeyer JM; Dobmeyer TS; Pape M; Ottmann OG; Helm EB; Hoelzer D; Rossol R AIDS; 1997 Jul; 11(9):1111-8. PubMed ID: 9233457 [TBL] [Abstract][Full Text] [Related]
13. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy. Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710 [TBL] [Abstract][Full Text] [Related]
14. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy. Imami N; Antonopoulos C; Hardy GA; Gazzard B; Gotch FM AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1499-508. PubMed ID: 10580400 [TBL] [Abstract][Full Text] [Related]
15. Dynamic changes of Th1/Th2/Th17 cytokines and human beta defensin 2 in HIV-infected patients with oral candidiasis during the first year of highly active anti-retroviral therapy. Yong X; Liu Z; Jiang L; Tao R; Liu W; Zhang L; Peng Y; Lin X; Huang Y Arch Oral Biol; 2018 Aug; 92():62-67. PubMed ID: 29753928 [TBL] [Abstract][Full Text] [Related]
16. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection. Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466 [TBL] [Abstract][Full Text] [Related]
17. TH1/TH2 cytokine levels as an indicator for disease progression in human immunodeficiency virus type 1 infection and response to antiretroviral therapy. Osakwe CE; Bleotu C; Chifiriuc MC; Grancea C; Oţelea D; Paraschiv S; Petrea S; Dinu M; Băicuş C; Streinu-Cercel A; Lazăr V Roum Arch Microbiol Immunol; 2010; 69(1):24-34. PubMed ID: 21053781 [TBL] [Abstract][Full Text] [Related]
19. Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure. Correa R; Harari A; Vallelian F; Resino S; Munoz-Fernandez MA; Pantaleo G AIDS; 2007 Jan; 21(1):23-30. PubMed ID: 17148964 [TBL] [Abstract][Full Text] [Related]
20. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir. Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]